Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus - Scorecard - MDSpire

Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus

  • By

  • Yijun Lin

  • Yao Yao

  • Xiaocui Miao

  • Shumin Tang

  • Libin Huang

  • October 31, 2025

  • 0 min

Share

Clinical Scorecard: Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus

At a Glance

CategoryDetail
Condition
Key MechanismsProgressive corneal thinning and deformation, influenced by genetic, environmental, and inflammatory factors, particularly the role of inflammatory cytokines.
Target Population
Care Setting

Key Highlights

  • Tear fluid biomarkers may enhance early diagnosis of keratoconus.
  • Machine learning models improve diagnostic accuracy by analyzing biomarker interactions.
  • Current diagnostic methods often fail to detect early-stage keratoconus, highlighting the need for innovative approaches.

Guideline-Based Recommendations

Diagnosis

  • Utilize corneal topography and tomography for structural assessment.
  • Incorporate tear fluid biomarker analysis for early detection.
  • Consider corneal biomechanical measurements as an adjunct diagnostic tool.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Integration of tear biomarker profiles with machine learning can predict KC progression, particularly through the analysis of inflammatory cytokines.

        Clinical Best Practices

        • Conduct thorough ocular examinations including slit-lamp and corneal tomography.
        • Collect tear samples for biomarker analysis in suspected keratoconus cases.
        • Use machine learning algorithms to enhance diagnostic accuracy, particularly in relation to tear biomarker profiles.

        References

        Original Source(s)

        Related Content